Anti-Arrhythmia Agents

Antihypertensive Agents

Vasodilator Agents

All Drugs and Chemicals

Anti-Inflammatory Agents

Other Dietary Supplements

Propranolol

Adrenergic beta-Antagonists

Adrenergic Agents

Omega 3 Fatty Acid

Addition of a treatment to normalise resting energy expenditure according to the observed abnormalities

Treatment to normalise resting energy expenditure according to the observed abnormalities such as anti-inflammatory treatment with Omega 3 in the case of systemic inflammation, treatment with a non-specific beta-blocker such as propanolol in the case of activation of the beta-adrenergic system, appropriate physical activity in the case of sarcopenia, or nutritional support aimed at re-establishing the balance of calorie and protein intake and expenditure, or a combination of these actions

Multimodal intervention

Christelle JADEAU

François GOLDWASSER, PHD

François Goldwasser, PHD

Pascaline BOUDOU-ROUQUETTE, MD

Half of all cancer patients show an increase in resting energy expenditure. The causes of hypermetabolism have only recently been investigated in cancerology. One established cause is inflammation, but other causes have yet to be identified.

The interest in hypermetabolism is due to the fact that it appears early, before the onset of clinical deterioration (weight loss, sarcopenia, altered performance status) and that it correlates with patient morbidity and mortality. Like the other parameters that make up cachexia, it is both a predictor of toxicity and reduced efficacy of anti-tumour treatments and a prognostic factor, regardless of the tumour.

A therapeutic goal is to correct hypermetabolism for two reasons:

* avoid progression to clinical cachexia, which is an independent cause of morbidity and mortality
* increase the efficacy of anti-PD1/PDL1 immunotherapies. This new class of therapy has revolutionised the therapeutic management of many cancers but is less effective in cases of inflammation and/or altered performance status and/or hypermetabolism.

Investigator hypothesises that it is possible to develop a patient-specific treatment to correct hypermetabolism, depending on the predominant clinical or biological cause.

Development of a Personalised Therapeutic Approach for Cancer Patients With Resting Hypermetabolism

The impact of a multimodal intervention is evaluated by proportion of hypermetabolic patients at 1 month in the personalised multimodal intervention arm compared to patients in the standard care arm

Centre Hospitalier le Mans

Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Nutritional and Metabolic Diseases

Symptoms and General Pathology

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Wasting Syndrome

Cachexia

Syndrome

Body Weight

Weight Loss

Body Weight Changes

Thinness

Metabolic Diseases

Nutrition Disorders

2 g EPA/DHA via fish oil daily Regular dietary counselling Twice weekly strength and cardiovascular exercise

2 g EPA/DHA as fish oil, repeated dietary counselling and twice weekly 2 x exercises

multimodal

Mette Holst, PhD

A single-arm intervention study assessing the feasibility of a multimodal intervention of management of cancer cachexia in patients with non-small cell lung cancer during primary anti-neoplastic treatment. The effects of the intervention is compared to a historical control group

In a single arm intervention study, we will provide a multimodal intervention consisting of dietary counselling, physical exercises plan as well as fish oil.

The target of the dietary counselling is:

* 30 kcal/kg/d (in patients with BMI \<30) or 25 kcal/kg/d (in patients with BMI =\> 30)
* at least 1.0 g protein/kg/d
* three daily meals of at least 20 g of protein
* restrict overnight fasting to a maximum of 11 hours

The initial dietary counselling is at the first cycle of anti-neoplastic treatment. The patient will be provided an individual plan to meet the dietary targets tailored to the individual preferences and symptoms. At every cycle of anti-neoplastic treatment, the plan will be adjusted if needed. At every week the patients will be prompted by telephone to comply with the dietary plan.

The physical exercise consists of two exercises:

* strength training: a progressive sit-to-stand exercise which is a lower extremity exercise.
* cardio-vascular training: a progressive brisk walking plan. Patients are prompted to execute both exercises twice weekly. The individual targets are set at the first cycle of anti-neoplastic treatment and adjusted during the trial.

Fish oil:

The patients are instructed to ingest 10g of liquid fish oil (consisting of 2 g EPA/DHA) or 8 capsules of fish oil (consisting of 2 g EPA/DHA)

This is a single arm intervention study, comparing the results to that of a historical control Group.

Multimodal Intervention for Patients With Non-small Cell Lung Cancer

Multimodal Intervention (Dietary Counselling, Fish Oil and Physical Training) for Patients With Non-small Cell Lung Cancer, a Feasibility Study

Recruitment rate is measured by dividing the number of patients consented by the number of patients screened

Retention rate is measured by dividing the number of patients completing the trial with the number of patients consented

The overall compliance was defined successful if at least half of the included patients reached at least 75 % of the nutrient target, consumed at least 75 % of the fish oil and conducted at least 50 % of the physical exercises

Change in skeletal muscle was measured using CT scans, analysed at the 3rd lumbar vertebra, expressed as actual change in square centimeter. Using an ordinal logistic regression model, patients were ordered in three Groups (muscle wasting: loss of at least 6 cm\^2 ; muscle maintenance: +/- 5.9 cm\^2; muscle gain: gain of at least 6.0 cm\^2). The baseline variables included in the model are age, gender, tumor stage, type of treatment, performance status, inflammatory score (mGPS) and cachexia. The possible prognostic factors included in the model is change in body weight, adherence to the anti-neoplastic treatment plan, treatment response, compliance to the multimodal intervention, number of Nutrition impact symptoms, days in between CT scans, energy and protein intake.

The change in body weight (measured at baseline and at the end of the trial using body weight scales, expressed as %

Change in skeletal muscle (measured using CT scans, expressed as actual muscle change at the 3rd lumbar vertebra in mean (SD) cm\^2

expressed as number of patients. Gaining defined as at least +6 Square centimeter skeletal muscle. Maintaining defined as: +/- 5.9 Square centimeter skeletal muscle. Wasting defined as: at least -6 Square centimeter skeletal muscle

assessed by timed-up-and-go test (expressed in number of seconds) and assessed by 30 seconds sit-to-stand test (expressed as number of stands).

Aalborg University Hospital

Ph.D. student

Antirheumatic Agents

Analgesics

Celecoxib

Nutritional supplements aimed at optimal energy balance and protein intake (2 cartons of ProSure per day), nutritional advice, home-based self-assisted exercise program and anti-inflammatory treatment (300 mg celecoxib) for 6 weeks. The aerobic exercise program is performed as self-administered daily walking sessions, aiming for a minimum of two sessions 30 minutes on a weekly basis. Other aerobic activities could be used instead of walking. The resistance exercise program should be performed 3 times weekly and lasts about 20 minutes. The program is targeting major muscle groups in the upper body and legs with use of weights. The intensity of the exercise and performance of the exercises are adapted to the individual patient's disease burden and physical performance.

Standard care

Stein Kaasa, MD, PhD

Ken Fearon, MD, PhD

A multicentre, open, randomized phase II study comparing a multimodal intervention (oral nutritional supplements, celecoxib and physical exercise) for cachexia versus standard cancer care.

A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study

The aim of this study is to investigate the feasibility of the multimodal intervention for cancer cachexia by assessing; enrolment rate, compliance with study intervention, contamination-rate in the control group with respect to any of the interventions.

University of Edinburgh

Oslo University Hospital

NHS Greater Glasgow and Clyde

Copenhagen University Hospital at Herlev

Norwegian University of Science and Technology

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Urinary Bladder Neoplasms

Urologic Neoplasms

Urogenital Neoplasms

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Urinary Bladder Diseases

Urologic Diseases

Male Urogenital Diseases

Intervention group will be assigned to specific decribed multimodal intervention

Patients in the intervention group will be taught to manage their new urinary diversion BEFORE operation. Traing kit will be provided so they can train the procedure forehanded. Second they will get a personally physical training program to optimize the total body function before operation. Nutritional status will be meassured and appropriate advices will be given BEFORE operation.

After operation the intervention group will be mobilised in a fast speed compared to standard care.

Multimodal Intervention

Michael Borre, PH.D

The incidence of bladder cancer is increasing. Denmark have approximately 1800 incidence per year. The disease is most frequently in males above the age of 70 years. In invasive bladdercancer surgery including removal of the seak bladder with constructing of a new diversion, is the first line treatment. However the procedure is followed by a high morbidity and convalescence. Extended surgical procedure cause pain, stress-induced metabolism and impaired organ function resulting in postoperative complications impacting on rehabilitation. The combination of extended surgery and the increasing numbers of elderly comorbid patients with invasive bladder cancer challenge professional treatment and care

The aim of the study is to investigate the efficacy of a multiprofessional rehabilitation programme for patients with invasive bladder cancer referred to surgery

Material and Methods The study is a randomised controlled trial. All patients \> 18 years referred to radical cystectomy will be eligible for this study. The efficacy is primary expressed by the difference in length of stay(LOS). Secondly by complications, health related quality of life(HRQoL) and patient reported quality of care during hospitalization. The intervention includes precise instructions and educations in intensive pre- and postoperatively exercises and stoma-care, supported by the multiprofessional team.

Perspective It is a national goal to improve cancer care. This study is of critical importance and places great emphasis on the patients perspective and involvement in a successful outcome for participant's and involvement in nutritional support, intensive exercises and stoma care, supported by the multidisciplinary team

PhD protocol

Efficacy of Multi-professional Rehabilitation in Patients with Bladder Cancer (offered radical cystectomy)

Bente Thoft Jensen, RN, MPH, research nurse Department of Urology Aarhus University Hospital, Skejby

Supervisors:

Michael Borre, associate professor, DMSc, PhD, Department of Urology, Aarhus University Hosptial, Skejby (head supervisor).

Klaus Ernst-Møller Jensen, consultant, DMSc, Department of Urology, Aarhus University Hospital, Skejby

Sussie Laustsen, associate professor, PhD, Clinical Institut, Aarhus University

Mette Krintel Petersen, post-doc, PhD, research physiotherapist, Department of Physiotherapy and Occupational Therapy, Aarhus University Hospital, Skejby

Collaborators:

Department of Physiotherapy and Occupational Therapy, Aarhus University Hospital, Skejby Mette Borre, dietician, Department of Gastroenterology and Hepatology, Aarhus University Hospital, Aarhus Sygehus, Norrebrogade Berit Kiesby, stoma-care nurse, Department of Urology, Aarhus University Hospital, Skejby

Background In Denmark, the incidence of patients with bladder cancer is approximately 1800 cases annually; 75% of the cases are men. The disease is most frequent among the 50 to 80-year-olds and most cases are approximately 70 years old \[1\]. Recent studies have shown that the incidence of bladder cancer is increasing in Europe\[2\]. Cystectomy is one of the most comprehensive surgical procedures in urology\[3,4\]. In Denmark, the average post-operative length of stay (LOS) was 19 days in 2005; the hospital mortality rate was 3.7% and 58% had a complicated course of disease. The mortality was comparable to experiences abroad \[3,5\]. LOS is, however, long compared with high-volume hospitals with well-defined clinical patient pathways \[1,5,6\]. Major surgery causes pain and stress-induced catabolism leading to an unwanted metabolic and inflammatory response, impaired organ function and risk of thrombosis. These conditions increase the risk of losing muscle mass and reduce the activity level \[2\]. Overall, the above-mentioned circumstances delay the rehabilitation process. The concept "fast-track surgery" is a multi-modal and inter-professional approach to reduce post-surgical morbidity and optimise post-surgical rehabilitation \[7,8\].

The multi-modal approach comprises both pre-operative optimisation of organ function, patient education, effective pain management, early post-operative mobilisation and early oral nutrition \[9\]. The concept has proven effective, though primarily documented in connection with colorectal surgery \[9-11,12,13,\], with increased survival, reduced LOS and reduced costs compared with conventional patient pathways\[14,15\]. The combination of a major surgical intervention and an increasing number of elderly comorbid patients with bladder cancer poses a challenge to treatment and care in all phases of the patient pathway. The above studies primarily focus on the pre- and post-operative effort. Evidence is sparse concerning the importance of an optimised pre-operative effort in rehabilitation \[11\]. It is hypothesised that an optimised patient pathway calls for an inter-professional pre-operative clinical evaluation and a pre-optimisation of the patient's general condition including nutrition and physical activity\[11,16-18\]. There is low evidence of the efficacy of multi-modal pre-optimisation efforts in major surgical procedures in urology \[2,19\]. Especially concerning the importance of a multi-facilitated pre-operative intervention for rehabilitation and health-related quality of life \[7,8\]. Generally, there has been a post-operative effect concerning early nutritional intervention and LOS \[20\]. Early nutritional intervention increases the number of patients fulfilling the threshold for sufficient nutritional status \[15,21\]. Nutrition strategies are increasingly combined with physical training consisting of exercise to increase muscle strength and endurance, to increase hypertrophy of muscle cells by increasing muscle protein synthesis and reducing disintegration \[22\]. Thus, a pre-operative multi-modal intervention involving nutritional optimisation and physical training should be a part of future studies. A muli-modal patient pathway will involve expectations of an increased risk that the economic burden will shift to the primary sector \[23\], an increased frequency of readmissions, complications and reduced quality of life. This thesis investigates the efficacy of pre- and post-operative multi-modal interventions in the rehabilitation of patients with bladder cancer undergoing cystectomy.

Material: All patients undergoing cystectomy at Aarhus University Hospital in 2009 fulfilling the inclusion criteria.

Study A. To investigate the efficacy of pre- and post-operative multi-modal intervention in bladder cancer patients referred to radical cystectomy

The following hypotheses are tested:

* An inter-professional multi-modal pre- and post-operative intervention promotes rehabilitation and reduces length of stay
* The intervention group obtains a higher functional and activity level compared with the control group
* The intervention group obtains a better management of urinary diversion compared with the control group

Material and methods:

Primary endpoints: LOS is defined as number of post-operative days (until 7 defined discharge criteria are fulfilled). The outcome data will be presented approximately 12 months after inclusion have been closed

Secondary endpoints:

* complications ( measured at discharge and 120 days postoperatively in average)
* Activity and functional level( will be measured every day during admission and 120 days after discharge).Pfysical parametres like bioimpedance, musclepower and handgrip strength will be measured at baseline( two weeks before operation, one day before operation, at discharge and 120 days after operation in both arms)
* Patient-experienced quality during admission ( measured with EORTC-questionaire at discharge in both arms)Informations will be presented approximately 12 months after inclusion is closed
* Health-related quality of life will be measured at baseline and 120 days after operation ( EORTC questionaire).
* Management of urinary diversion will be measured at baseline, before operation,35 days and 120 days after operation.A validated stoma score scale for patient stoma skills will be used.The outcome data will be presented approximately 12 months after inclusion have been closed

Sample size. The study population is calculated on the basis on LOS for patients undergoing cystectomy at the Department of Urology, Aarhus University Hospital, Skejby in 2008. Average LOS was 13 days with a standard deviation of 4.75 days. Risk of type 1 error was 5% at a 2-sided analysis and strength at 80%. Lowest relevant difference in effect is a 20% reduction in LOS in the intervention group. When a 2-sided comparison is made, 92 patients have to be included; 46 in the intervention and control group, respectively.Written information about the study is forwarded to the patients along with the appointment for a uro-oncological evaluation.

Randomisation: Performed 14-17 days prior to surgery. When deciding on surgery the patient receives oral information about the examination. After time for deliberation and giving informed consent, the patients are randomised at the outpatient consultation following the uro-oncological evaluation.

Monitoring:

Demographic and clinical background variables are registered at baseline. Follow-up after 4 months. Data are collected for further analysis at 1-year follow-up (appendix 1.1-1.5). All patients undergo nutritional screening at baseline by NRS \[32,33\].

Patients with age-adjusted score\<3 will receive supplements according to standard criteria\[25-28\]. Energy demand is calculated as weight x100x1.3 KJ /day. Protein need is calculated as weight x 1.5 gram protein/day. Fluid need is calculated as weight x 30 ml/day \[30\]. Comorbidity is scored using the Charlson index score, pain and nausea using the VAS-score \[32,33\].Habitual intestinal function is scored using the Bristol scale\[34\].

Physical activity level is estimated at baseline using the Physical Activity Scale (PAS) \[35\]. Daily mobilisation time and walking distance are registered pre-operatively and during admission using a pedometer \[36,37\].

Ability to perform personal activities of daily living are evaluated daily during admission using the KATZ score \[38\].

Muscle power, muscle strength and body composition are registered at baseline, pre-operatively, at discharge and 35, 120 (and 365) days post-operatively. Muscle power (force x velocity) is evaluated by leg extensor power Rig \[39\]; Isometric muscle strength (hand grip strength) is evaluated by "Good Muscle Strength" \[40\]and body composition is evaluated by bioimpedance \[41\] Progression in management of urinary diversion is evaluated by a categorial scale (appendix 1.4).

Standard treatment:

Patients eat normally until the operation. The rectal ampulla is emptied the evening before surgery. From midnight the patients fast and drink two glasses of sweet juice at 06.00 am before the operation. TED stockings are used to prevent thrombosis per- and post-operatively until the mobilisation criteria have been met. 5000 IU of Fragmin are injected subcutaneously from day 0. Individual prescriptions are made for patients with sclerotic diseases. Per-operative infection prophylaxis is standardised.

Sevofluorane is used as a sedative and Bupivacain as well as Ultiva infusions as pain management. Epidural catheter is used for pain treatment at th-12-L1 level. The transfusion regime is standardised. Pain treatment: Post-operatively - epidurally administered Bupivacain 2.5 mg /ml 5-6 ml / h in 3 full days. Peripheral pain treatment is tablet paracetamol 1g x 4 and from day 2, two tablets Ibuprofen 400 mg x 3.

* Care of urinary diversion; When surgery is decided there is an interprofessional meeting concerning management of stoma and neobladder. Stoma markings are made the day before surgery in collaboration with the surgeon, the patient and the stoma care nurse. Relevant aids are demonstrated and the post-operative regime is presented.
* Physiotherapy: Instruction and information about pulmonary physiotherapy is performed pre-operatively. Daily mobilisation in each shift post-operatively.
* Discharge criteria (see appendix 1.5)

Intervention

In addition, the following initiatives are made in the intervention group:

* Pre-operative optimisation: The intervention group is taught pre-operatively about the management of urinary diversion. Exercise kit is handed out with exercises to perform in the home. Intensive instruction and teaching is provided by physiotherapist. Moreover, plans for post-operative progressive mobilisation and transfer techniques. Balancing mutual expectations for the entire intervention.
* Post-operative optimisation: Intensive, structured and progressive plans for daily mobilisation and physical activity from the day of surgery until planned discharge at 7-9 post-operative day as well as instruction in urinary diversion by the stoma care nurse.

Effect: Expressed as the difference in: LOS, complications, functional and activity level and management of urinary diversion.

Statistics: Normally distributed data are described as mean, standard deviation (SD) and 95% confidence intervals (CI) and tested with Student's t-test for paired data, unpaired data are tested by unpaired t-test and repeated measurements. Non-normally distributed data are described as median and range and tested by the Mann-Whitnew U-test or Wilcoxon's sign rank test. When testing 3 or more variables the Friedman test is applied. Pearson's test is applied in correlation analyses if conditions are met or Spearman's Rho. Frequencies are compared by Fischer's exact test. Associations between variables are reported as odds ratios and 95% CI.

Study B: Health-related quality of life and experienced patient quality in multi-modal interventions

Purpose: to study the effect of multi-modal interventions concerning the patient experience during hospital admission and health-related quality of life (HeQoL).

Hypothesis:

The intervention group will have better experienced quality and higher HeQoL. End points: Score concerning HeQoL and patient experienced quality. Material /Method: Same method and study population as in study 2. Disease-specific questionnaires from the European Organisation for Research and Treatment of Cancer, EORTC QLQ-BLM30 and QLQ-C30 \[42\] were applied. Scores are made at baseline and follow-up at planned control visits (35 days, 120 days and 365 days). At discharge EORTC In-PATSAT32 is used to evaluate the patient experience of quality during admission. All questionnaires are validated and translated into Danish \[43,44\].

Statistics study B. Data are registered at a categorial scale and described as mentioned in study A for non-normally distributed data. Wilcoxon's sign rank test is used to test the difference in HeQoL between the groups.When testing 3 or more groups, Friedman's test is applied. Spearman's Rho is used for correlation analyses of non-normally distributed data. Associations between variables are reported as ORs and 95% CI.

Ethical considerations: The study is approved by the Central Denmark Committee on Biomedical and Research Ethics and the Danish Data Agency. Transport costs in connection with control visits are refunded and it is attempted that examinations take place at days where the patient has to meet for a control visit at the hospital. At present, the treatment offer to this patient group does not include pre- and post-operative optimisation and it is not deemed unethical to randomise patients to pre- or post-operative optimisation or standard treatment, respectively. The study is registered in the American clinical database www.clinicaltrials.gov.

Research plan including time schedule: Daily project management, data processing and statistical analyses will be made and interpreted by PhD student Bente Thoft Jensen(BTJ), who is also responsible for publication of results. Data collection will be made in collaboration with the stoma care and nutrition responsible nurses and a dietician. Instruction in home exercises, test of functional and activity level is made in collaboration with the physiotherapists in the bladder team. The project is expected to start in the spring 2011. Inclusion of patients will run for 1.5 years according to the current surgical activity. Data collection and analyses are made in 2011 and 2012. Summary and reporting of results will be made in 2012.

Publication: The project results are communicated in 3 peer-reviewed articles and in a PhD thesis.

Funding:The project will be partly financed by the Department of Urology, Aarhus University Hospital, Skejby (1/3), by the hospital management teat, Aarhus University Hospital, Skejby (1/3) and the rest will be university scholar ships, industrial collaborators and foundations.

Perspective: Cystectomy is one of the most resource-consuming surgical procedures. Despite comprehensive shifts in paradigms in both nursing and treatment strategies throughout the last decade, the average LOS has only been modestly reduced. In addition to the newly introduced packages for diagnostics and treatment of cancer patients it is essential to strengthen the overall effort. This PhD project should be seen as a part of the endavour to fulfil all parts of the overall purpose concerning evidence-based optimisation of the rehabilitation of bladder cancer patients. Whether urological patient pathways with a pre-operative intervention can minimise post-operative complications, lead to a higher HeQoL and shorten the rehabilitation period will be highlighted.

Multimodal Rehabilitation Program to Bladder Cancer Patients

Efficacy of a Multimodal Rehabilitation Program to Bladder Cancer Patients

* Primary Endpoint is the difference in the length of stay (LOS) between the standard care gruop and the intervention group.
* LOS will be measuared when the 7 defined standard discharge criteria are fulfilled. The difference between the primary outcome will be compared and published approximately 12 months after inclusion is closed

* HeQoL will be measured at baseline and 120 days postoperatively.( EORTC questionaire)
* Complications postoperatively will be meassured at discharge and at 120 days postoperatively with the listed domaines on the Memorial Sloan Kettering Tool.
* Management of the urinary diversion will be measured on a patient stoma skill score ( baseline, before operation, +35 days and at 120 days)
* All outcomes is expected to be published in 12 months on average after operation

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Development of a Personalised Therapeutic Approach for Cancer Patients With Resting Hypermetabolism	NCT05281354	Cancer	Multimodal inte...	18 Years -	Centre Hospitalier le Mans
Multimodal Intervention for Patients With Non-small Cell Lung Cancer	NCT04161794	Cachexia; Cance...	multimodal	18 Years -	Aalborg University Hospital
Multimodal Intervention for Patients With Non-small Cell Lung Cancer	NCT04161794	Cachexia; Cance...	multimodal	18 Years -	Aalborg University Hospital
A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study	NCT01419145	Cancer Cachexia	Multimodal inte... Standard care	18 Years - 80 Years	Norwegian University of Science and Technology
Multimodal Rehabilitation Program to Bladder Cancer Patients	NCT01329107	Bladder Cancer	Multimodal Inte...	18 Years -	University of Aarhus

Spots Global Cancer Trial Database for multimodal intervention